Analyst Consensus
- Current Price
- 119.54 $
- Target (Low)
- 84.98 $
- Target (Mean)
- 127.05 $
- Target (High)
- 150.00 $
- Recommendation
- Buy
- Number of Analysts
- 21
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 13 |
|---|
| Hold | 8 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 19.7%
- Operating Margin
- 25.0%
- Gross Margin
- 64.3%
- Return on Equity (ROE)
- 25.2%
- Return on Assets (ROA)
- 7.3%
- Revenue Growth
- 12.0%
- Earnings Growth
- 37.1%
- Debt/Equity
- 67.54
- Current Ratio
- 0.93
- Beta
- 1.00
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 12, 2026 | Morgan Stanley | Overweight → Overweight |
| Jun 8, 2026 | B of A Securities | Buy → Buy |
| May 26, 2026 | B of A Securities | Buy → Buy |
| May 15, 2026 | HSBC | Hold → Buy |
| May 15, 2026 | Barclays | Equal-Weight → Equal-Weight |
| May 14, 2026 | UBS | Buy → Buy |